References for this Review were identified through searches of PubMed with the search terms “cell-based and pharmacological therapies”, “experimental stroke”, “restorative therapies”, “neurogenesis”, “angiogenesis”, “MRI”, from January, 1975, to January, 2009. Papers for cell-based and pharmacological therapies were only included if treatments were initiated 24 h or longer after stroke. Only papers published in English were reviewed.
ReviewNeurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Introduction
Stroke is a major cause of morbidity and mortality worldwide. Thrombolytic therapy with alteplase is effective when given within 4·5 h after stroke.1, 2 However, fewer than 5% of patients with ischaemic stroke in the USA receive this treatment. Even with effective thrombolysis, most patients will have neurological deficits.3, 4 Therefore, development of therapies for ischaemic stroke designed specifically to reduce neurological deficits is crucial.
Preclinical data indicate that cell-based and pharmacological therapies that enhance brain-repair processes substantially improve functional recovery when given 24 h or later after stroke or brain injury.5, 6, 7, 8, 9, 10, 11, 12, 13 Cell-based therapies under investigation include use of bone-marrow mesenchymal cells, cord blood cells, fetal cells, and embryonic cells.12, 14, 15, 16, 17, 18, 19, 20 Pharmacological treatments include drugs that increase cGMP (eg, phosphodiesterase 5 inhibitors, such as sildenafil and tadalafil), statins, erythropoietin, granulocyte-colony stimulating factor, nicotinic acid, and minocycline.6, 7, 10, 21, 22, 23, 24, 25 The common restorative characteristic of these therapies is that they target many types of parenchymal cells (including neural stem cells, cerebral endothelial cells, astrocytes, oligodendrocytes, and neurons), leading to enhancement of endogenous neurogenesis, angiogenesis, axonal sprouting, and synaptogenesis in ischaemic brain tissue. These events collectively improve neurological function after stroke. Furthermore, in addition to providing enhanced cerebral tissue perfusion, angiogenic vessels produce neurotrophic compounds, which create a suitable microenvironment within the injured brain that attracts endogenous stem cells and promotes integration of these cells within the parenchyma. Together with parenchymal astrocytes, angiogenic vessels contribute to enhancement of synaptogenesis and axonal sprouting.
In this Review, we describe the mechanisms by which cell-based and pharmacological treatments stimulate endogenous brain remodelling after stroke, particularly neurogenesis, angiogenesis, axonal plasticity, and white-matter change. We also briefly outline the potential of MRI to view these restorative events. Finally, we discuss the challenges of translating these therapies into the clinic and ongoing clinical trials.
Section snippets
Enhancement of neurogenesis
The subventricular zone (SVZ) of the lateral ventricle and the dentate gyrus of the hippocampus of adult rodent brains contain neural stem cells that produce neuroblasts.26, 27 Under physiological conditions, neuroblasts in the SVZ travel via the rostral migratory stream to the olfactory bulb where they differentiate into granule and periglomerular neurons throughout adult life.27, 28 In the SVZ of adult human brains, neural stem cells are present in a band of astrocytes separated from the
Enhancement of cerebral angiogenesis
The cerebral vascular system mainly develops through angiogenesis.70 Although proliferation of cerebral endothelial cells ceases in the adult brain, angiogenesis in adult human and rodent brains can take place under pathophysiological conditions.71, 72 In the rodent brain, capillary sprouting is initiated at the border of the infarct and new vessels develop in the ischaemic boundary between 2 and 28 days after the onset of stroke,73, 74 whereas angiogenesis takes place in the penumbra of human
Coupling of neurogenesis and angiogenesis
Stroke induces angiogenesis and neurogenesis, two processes that are linked together.71, 74, 81, 84, 85, 98, 99, 100, 101, 102 Cerebral blood vessels mainly provide nutritive blood flow. However, cerebral endothelial cells secrete factors that regulate the biological activity of neural progenitor cells. Under physiological conditions, neurogenesis in the subgranular zone of the dentate gyrus takes place within an angiogenic microenvironment.103 The laminin receptor α6β1 integrin expressed by
Effects on astrocytes, oligodendrocytes, and axons
Axons in ischaemic brains have little capability to sprout.118 Astrocytes form glial scars along ischaemic lesions and produce proteoglycans that inhibit axonal growth and that act as physical and biochemical barriers to axonal regeneration.119 In experimental stroke, treatment with bone-marrow mesenchymal cells substantially increases axonal density around the ischaemic lesion, extends axonal fibres, and orients these fibres parallel to the boundary of a coronal section of an ischaemic lesion.
Translation to the clinic
Apart from treatment with alteplase, translation of therapies for stroke to the clinic from those in the laboratory has not been successful.134 These attempts all aimed to develop neuroprotective treatments of stroke with early intervention to reduce the volume of cerebral infarction. Reasons for failure include the short time window required to intervene to salvage cerebral tissue. Many of the drugs tested in the laboratory were given immediately after or within the first hours after onset of
Clinical trials
Approaches to enhance recovery of function after stroke in the laboratory and in clinical trials extend beyond the use of drugs and cell-based treatments and include electromagnetic stimulation, device-based strategies, repetitive training, and task-oriented strategies.136 The recent Extremity Constraint Induced Therapy Evaluation (EXCITE) trial reported significantly positive results for distal and proximal arm motor function in response to constraint-induced therapy.139, 140 Here, we focus on
Conclusions
The cell-based and pharmacological therapies described in this Review target multiple types of parenchymal cells in ischaemic brain tissue to increase neurogenesis, angiogenesis, and axonal outgrowth during recovery. Potential mechanisms underlying these beneficial therapies are emerging. Future studies must investigate mechanisms that temporally and spatially coordinate these events.
Brain remodelling after stroke and subsequent improvement of functional outcome probably result from several
Search strategy and selection criteria
References (146)
- et al.
Recovery recapitulates ontogeny
Trends Neurosci
(2000) - et al.
Treatment of neural injury with marrow stromal cells
Lancet Neurol
(2002) - et al.
Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI
Neuroimage
(2005) - et al.
Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats
Brain Res
(2004) - et al.
Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke
Brain Res
(2006) - et al.
Neuronal progenitor cells derived from the anterior subventricular zone of the neonatal rat forebrain continue to proliferate in vitro and express a neuronal phenotype
Mol Cell Neurosci
(1997) - et al.
Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia
Neuroscience
(2001) - et al.
Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells
Dev Biol
(2005) - et al.
Ischemic stroke and neurogenesis in the subventricular zone
Neuropharmacology
(2008) - et al.
Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system
Curr Opin Cell Biol
(2005)
Roles of bHLH genes in neural stem cell differentiation
Exp Cell Res
The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells
J Biol Chem
Neurogenesis in adulthood: a possible role in learning
Trends Cogn Sci
Development and differentiation of endothelium
Kidney Int Suppl
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border
Cell
Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia
Trends Cardiovasc Med
Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat
Am J Pathol
Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis
Brain Res
Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF
J Cereb Blood Flow Metab
Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke
Brain Res
Prognostic value of blood vessel density in ischaemic stroke
Lancet
Measurement of cerebral microvessel diameters after embolic stroke in rat using quantitative laser scanning confocal microscopy
Brain Res
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
N Engl J Med
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
N Engl J Med
The role of polypeptide growth factors in recovery from stroke
Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat
Circ Res
Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats
Stroke
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
Ann Neurol
Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury
J Neurotrauma
Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells
Circulation
Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats
Stroke
Post-ischemic administration of heparin-binding epidermal growth factor-like growth factor (HB-EGF) reduces infarct size and modifies neurogenesis after focal cerebral ischemia in the rat
J Cereb Blood Flow Metab
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model
J Clin Invest
Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke
Cell Transplant
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats
Stroke
Stem cell therapy for human neurodegenerative disorders—how to make it work
Nat Med
Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy
Neuroscientist
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views
Stem Cells
A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats
Ann Neurol
Granulocyte-macrophage colony-stimulating factor as an arteriogenic factor in the treatment of ischaemic stroke
Expert Opin Biol Ther
Niaspan increases angiogenesis and improves functional recovery after stroke
Ann Neurol
Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats
Stroke
Neurogenesis in adult subventricular zone
J Neurosci
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain
J Neurosci
Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension
Science
Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells
J Comp Neurol
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration
Nature
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat
Proc Natl Acad Sci USA
Rat forebrain neurogenesis and striatal neuron replacement after focal stroke
Ann Neurol
Neuronal replacement from endogenous precursors in the adult brain after stroke
Nat Med
Cited by (518)
Extracellular vesicles: Mediators of microenvironment in hypoxia-associated neurological diseases
2024, Clinical Neurology and NeurosurgeryLoss of Gucy1a3 causes poor post-stroke recovery by reducing angiogenesis via the HIF-1α/VEGFA signaling pathway in mice
2024, Journal of Stroke and Cerebrovascular DiseasesThe role of RhoA/ROCK pathway in the ischemic stroke-induced neuroinflammation
2023, Biomedicine and PharmacotherapyButyrate promotes post-stroke outcomes in aged mice via interleukin-22
2023, Experimental NeurologyCharacteristics and pathogenesis of chemokines in the post-stroke stage
2023, International Immunopharmacology